| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |